These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26506440)

  • 1. Penetrance of pathogenic mutations in haploinsufficient genes for intellectual disability and related disorders.
    Ropers HH; Wienker T
    Eur J Med Genet; 2015 Dec; 58(12):715-8. PubMed ID: 26506440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
    Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
    Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
    Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions.
    Yu KP; Luk HM; Fung JLF; Chung BH; Lo IF
    Eur J Med Genet; 2021 Jan; 64(1):104107. PubMed ID: 33242595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.
    Kuechler A; Czeschik JC; Graf E; Grasshoff U; Hüffmeier U; Busa T; Beck-Woedl S; Faivre L; Rivière JB; Bader I; Koch J; Reis A; Hehr U; Rittinger O; Sperl W; Haack TB; Wieland T; Engels H; Prokisch H; Strom TM; Lüdecke HJ; Wieczorek D
    Eur J Hum Genet; 2017 Feb; 25(2):183-191. PubMed ID: 27901041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo nonsense variant in ASXL3 in a Chinese girl causing Bainbridge-Ropers syndrome: A case report and review of literature.
    Wang Q; Zhang J; Jiang N; Xie J; Yang J; Zhao X
    Mol Genet Genomic Med; 2022 May; 10(5):e1924. PubMed ID: 35276034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bainbridge-Ropers syndrome with ASXL3 gene variation in a child and literature review].
    Zhang R; He XH; Lin HY; Yang XH
    Zhonghua Er Ke Za Zhi; 2018 Feb; 56(2):138-141. PubMed ID: 29429203
    [No Abstract]   [Full Text] [Related]  

  • 8. A de novo nonsense mutation in
    Koboldt DC; Mihalic Mosher T; Kelly BJ; Sites E; Bartholomew D; Hickey SE; McBride K; Wilson RK; White P
    Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29305346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the neurodevelopmental and motor phenotypes of Bohring-Opitz syndrome (ASXL1) and Bainbridge-Ropers syndrome (ASXL3).
    Ayoub MC; Anderson JT; Russell BE; Wilson RB
    Front Neurosci; 2023; 17():1244176. PubMed ID: 38027485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Bainbridge-Ropers Syndrome in
    Lichtig H; Artamonov A; Polevoy H; Reid CD; Bielas SL; Frank D
    Front Physiol; 2020; 11():75. PubMed ID: 32132929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.
    Srivastava A; Ritesh KC; Tsan YC; Liao R; Su F; Cao X; Hannibal MC; Keegan CE; Chinnaiyan AM; Martin DM; Bielas SL
    Hum Mol Genet; 2016 Feb; 25(3):597-608. PubMed ID: 26647312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
    Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
    Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Penetrance for Ocular Phenotype in Two Individuals Carrying Heterozygous Loss-of-Function
    Dudakova L; Stranecky V; Piherova L; Palecek T; Pontikos N; Kmoch S; Skalicka P; Vaneckova M; Davidson AE; Liskova P
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33946386
    [No Abstract]   [Full Text] [Related]  

  • 16. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with
    Balasubramanian M; Willoughby J; Fry AE; Weber A; Firth HV; Deshpande C; Berg JN; Chandler K; Metcalfe KA; Lam W; Pilz DT; Tomkins S
    J Med Genet; 2017 Aug; 54(8):537-543. PubMed ID: 28100473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
    Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
    Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants in FRYL are associated with developmental delay, intellectual disability, and dysmorphic features.
    Pan X; Tao AM; Lu S; Ma M; Hannan SB; Slaugh R; Drewes Williams S; O'Grady L; Kanca O; Person R; Carter MT; Platzer K; Schnabel F; Abou Jamra R; Roberts AE; Newburger JW; Revah-Politi A; Granadillo JL; Stegmann APA; Sinnema M; Accogli A; Salpietro V; Capra V; Ghaloul-Gonzalez L; Brueckner M; Simon MEH; Sweetser DA; Glinton KE; Kirk SE; ; Wangler MF; Yamamoto S; Chung WK; Bellen HJ
    Am J Hum Genet; 2024 Apr; 111(4):742-760. PubMed ID: 38479391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood-onset generalized epilepsy in Bainbridge-Ropers syndrome.
    Myers KA; White SM; Mohammed S; Metcalfe KA; Fry AE; Wraige E; Vasudevan PC; Balasubramanian M; Scheffer IE
    Epilepsy Res; 2018 Feb; 140():166-170. PubMed ID: 29367179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
    Bedoukian E; Copenheaver D; Bale S; Deardorff M
    Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.